Nutriband Income Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Revenue	1.62	2.04	2.14	2.09	2.08	1.42
Revenue Growth	-37.25%	-4.81%	2.60%	0.27%	46.23%	50.70%
Cost of Revenue	1.08	1.47	1.4	1.22	1.33	0.92
Gross Profit	0.54	0.57	0.74	0.86	0.75	0.5
Selling, General & Admin	6.37	6.99	4.31	3.77	3.92	4.02
Research & Development	1.21	1.89	3.12	1.96	0.98	0.41
Operating Expenses	7.58	8.88	7.43	5.73	4.9	4.43
Operating Income	-7.05	-8.32	-6.69	-4.87	-4.15	-3.93
Interest Expense	-0.03	-0.02	-0.02	-0.08	-0.01	-0.12
Interest & Investment Income	-	-	-	0.02	-	-
Other Non Operating Income (Expenses)	0.11	0.11	0.19	-	-	-
EBT Excluding Unusual Items	-6.96	-8.23	-6.52	-4.93	-4.16	-4.05
Impairment of Goodwill	-	-	-3.6	-	-0.33	-2.18
Other Unusual Items	-	-	-0.37	-0.55	-	0.05
Pretax Income	-6.96	-8.23	-10.48	-5.49	-4.48	-6.18
Net Income	-6.96	-8.23	-10.48	-5.49	-4.48	-6.18
Preferred Dividends & Other Adjustments	-	21.81	-	-	-	0.2
Net Income to Common	-6.96	-30.04	-10.48	-5.49	-4.48	-6.37
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	12	12	11	8	8	8
Shares Outstanding (Diluted)	12	12	11	8	8	8
Shares Change	8.93%	9.74%	33.36%	-5.97%	6.64%	17.82%
EPS (Basic)	-0.57	-2.58	-0.99	-0.69	-0.53	-0.80
EPS (Diluted)	-0.57	-2.58	-0.99	-0.69	-0.53	-0.80
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Free Cash Flow	-3.63	-5.14	-4.72	-3.58	-3.07	-2.89
Free Cash Flow Per Share	-0.30	-0.44	-0.45	-0.45	-0.36	-0.36
Gross Margin	33.14%	27.81%	34.74%	41.34%	36.08%	35.46%
Operating Margin	-435.58%	-408.41%	-312.67%	-233.63%	-199.45%	-276.33%
Profit Margin	-430.43%	-1475.16%	-489.95%	-263.05%	-215.59%	-448.10%
Free Cash Flow Margin	-224.54%	-252.37%	-220.54%	-171.64%	-147.46%	-203.27%
EBITDA	-6.9	-8.12	-6.4	-4.58	-3.82	-3.62
EBITDA Margin	-	-	-299.34%	-219.83%	-183.58%	-254.63%
D&A For EBITDA	0.15	0.19	0.29	0.29	0.33	0.31
EBIT	-7.05	-8.32	-6.69	-4.87	-4.15	-3.93
EBIT Margin	-	-	-	-233.63%	-199.45%	-276.33%

SEC Filings: 10-K · 10-Q